New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Sexual dysfunction high among women with lung cancer

Sexual dysfunction high among women with lung cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainSexual dysfunction is highly prevalent in women with lung cancer with most survey participants reporting little to no interest in s
World medicine December 15,2023
Sexual dysfunction high among women with lung cancer

Sexual dysfunction high among women with lung cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainSexual dysfunction is highly prevalent in women with lung cancer with most survey participants reporting little to no interest in s
World medicine December 15,2023
2014 to 2021 saw increase in use of active surveillance for low-risk prostate cancer

2014 to 2021 saw increase in use of active surveillance for low-risk prostate cancer

by Elana GotkineFrom 2014 to 2021, the rates of active surveillance for low-risk prostate cancer increased, but considerable practice- and practitioner-level variation is seen in its use, according to
World medicine December 15,2023
2014 to 2021 saw increase in use of active surveillance for low-risk prostate cancer

2014 to 2021 saw increase in use of active surveillance for low-risk prostate cancer

by Elana GotkineFrom 2014 to 2021, the rates of active surveillance for low-risk prostate cancer increased, but considerable practice- and practitioner-level variation is seen in its use, according to
World medicine December 15,2023
Breakthrough in precision medicine for the treatment of acute myeloid leukemia

Breakthrough in precision medicine for the treatment of acute myeloid leukemia

byKarolinska InstitutetCredit:Journal of Internal MedicineResearchers at Karolinska Institutet, among others, have studied the benefit of adding an established drug as a novel targeted the
World medicine December 15,2023
Breakthrough in precision medicine for the treatment of acute myeloid leukemia

Breakthrough in precision medicine for the treatment of acute myeloid leukemia

byKarolinska InstitutetCredit:Journal of Internal MedicineResearchers at Karolinska Institutet, among others, have studied the benefit of adding an established drug as a novel targeted the
World medicine December 15,2023
2013 to 2017 saw significant drop in U.S. melanoma mortality rates

2013 to 2017 saw significant drop in U.S. melanoma mortality rates

by Elana GotkineThe introduction of new melanoma treatments coincided with a reduction in the melanoma mortality rate (MMR) in the United States, according to a study published online Dec. 6 inJ
World medicine December 15,2023
2013 to 2017 saw significant drop in U.S. melanoma mortality rates

2013 to 2017 saw significant drop in U.S. melanoma mortality rates

by Elana GotkineThe introduction of new melanoma treatments coincided with a reduction in the melanoma mortality rate (MMR) in the United States, according to a study published online Dec. 6 inJ
World medicine December 15,2023
A digital tool is helping cancer survivors cope with fear of recurrence

A digital tool is helping cancer survivors cope with fear of recurrence

by Ben Knight,University of New South WalesCredit: Tara Winstead from PexelsA self-guided digital intervention is showing promise for helping cancer survivors manage their post-treatment uncerta
World medicine December 15,2023
A digital tool is helping cancer survivors cope with fear of recurrence

A digital tool is helping cancer survivors cope with fear of recurrence

by Ben Knight,University of New South WalesCredit: Tara Winstead from PexelsA self-guided digital intervention is showing promise for helping cancer survivors manage their post-treatment uncerta
World medicine December 15,2023
First report from metastatic prostate cancer research project highlights patient perspectives

First report from metastatic prostate cancer research project highlights patient perspectives

by Alex Viveros,Broad Institute of MIT and HarvardThe team has successfully partnered with over 1,000 men with MPC across the United States and Canada. Credit : MPCprojectDespite having lived wi
World medicine December 15,2023
First report from metastatic prostate cancer research project highlights patient perspectives

First report from metastatic prostate cancer research project highlights patient perspectives

by Alex Viveros,Broad Institute of MIT and HarvardThe team has successfully partnered with over 1,000 men with MPC across the United States and Canada. Credit : MPCprojectDespite having lived wi
World medicine December 15,2023
Clinical trial sets stage for new paradigm in kidney cancer treatment

Clinical trial sets stage for new paradigm in kidney cancer treatment

byUT Southwestern Medical CenterStereotactic ablative radiation therapy (SAbR) instruments deliver potent, narrow beams of radiation to precisely target tumors adapting to changes in the tumor s
World medicine December 15,2023
Clinical trial sets stage for new paradigm in kidney cancer treatment

Clinical trial sets stage for new paradigm in kidney cancer treatment

byUT Southwestern Medical CenterStereotactic ablative radiation therapy (SAbR) instruments deliver potent, narrow beams of radiation to precisely target tumors adapting to changes in the tumor s
World medicine December 15,2023
Checklist for radical cystectomy in patients with spinal cord injury

Checklist for radical cystectomy in patients with spinal cord injury

by Anne Rommel, Leibniz-Institut für Arbeitsforschung an der TU DortmundCredit: Pixabay/CC0 Public DomainCancer is the third most common cause of death in people with spinal cord injury (SCI), with bl
World medicine December 15,2023
Checklist for radical cystectomy in patients with spinal cord injury

Checklist for radical cystectomy in patients with spinal cord injury

by Anne Rommel, Leibniz-Institut für Arbeitsforschung an der TU DortmundCredit: Pixabay/CC0 Public DomainCancer is the third most common cause of death in people with spinal cord injury (SCI), with bl
World medicine December 15,2023
Estimates and projections of the global economic cost of 29 cancers

Estimates and projections of the global economic cost of 29 cancers

byInternational Institute for Applied Systems AnalysisMacroeconomic Burden Due to Cancers From 2020 to 2050. INT$ indicates international dollars at constant 2017 prices. Credit:JAMA Oncol
World medicine December 15,2023
Estimates and projections of the global economic cost of 29 cancers

Estimates and projections of the global economic cost of 29 cancers

byInternational Institute for Applied Systems AnalysisMacroeconomic Burden Due to Cancers From 2020 to 2050. INT$ indicates international dollars at constant 2017 prices. Credit:JAMA Oncol
World medicine December 15,2023
Destroying tumor cells: Targeted immunotherapy using injectable materials

Destroying tumor cells: Targeted immunotherapy using injectable materials

by Terasaki Institute for Biomedical InnovationResearchers have developed a method for injectable, targeted delivery of immunotherapeutic treatments. The shear-thinning biomaterial is loaded with the
World medicine December 15,2023
Destroying tumor cells: Targeted immunotherapy using injectable materials

Destroying tumor cells: Targeted immunotherapy using injectable materials

by Terasaki Institute for Biomedical InnovationResearchers have developed a method for injectable, targeted delivery of immunotherapeutic treatments. The shear-thinning biomaterial is loaded with the
World medicine December 15,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com